Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

NCT00310180 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

10273

Enrollment

NIH

Sponsor class

Conditions

Breast Adenocarcinoma
Hormone Receptor Positive
Stage IA Breast Cancer AJCC v7
Stage IB Breast Cancer AJCC v7
Stage IIA Breast Cancer AJCC v6 and v7
Stage IIB Breast Cancer AJCC v6 and v7
Stage IIIB Breast Cancer AJCC v7

Interventions

DRUG: Anastrozole
DRUG: Exemestane
OTHER: Laboratory Biomarker Analysis
DRUG: Letrozole
OTHER: Quality-of-Life Assessment
RADIATION: Radiation Therapy
DRUG: Tamoxifen Citrate

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]